These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 392183)

  • 41. Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism.
    Sugimoto R; Watanabe H; Ikegami K; Enoki Y; Imafuku T; Sakaguchi Y; Murata M; Nishida K; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
    Kidney Int; 2017 Mar; 91(3):658-670. PubMed ID: 27988213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients.
    Coppolino G; Bolignano D; De Paola L; Giulino C; Mannella A; Riccio M; Mascaro MA; Lombardi G; Fuiano G; Lombardi L; Buemi M
    J Investig Med; 2011 Jun; 59(5):823-8. PubMed ID: 21383630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical, radiological and ultrasonic correlations in secondary hyperparathyroidism. Observations concerning 75 patients on dialysis].
    Giuseppetti GM; Giovagnoni A; Baldelli S; Macchini M; Bordoni E
    Radiol Med; 1986; 72(1-2):29-31. PubMed ID: 3515463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Target levels for serum phosphorus and parathyroid hormone.
    Qunibi W; Kalantar-Zadeh K
    Semin Dial; 2011; 24(1):29-33. PubMed ID: 21324001
    [No Abstract]   [Full Text] [Related]  

  • 45. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
    Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Intraoperative parathyroid hormone monitoring in neck exploration for renal hyperparathyroidism?].
    Walgenbach S; Junginger T
    Chirurg; 2002 Mar; 73(3):211-6. PubMed ID: 11963493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Parathyroid hormone, a simple hormone or uremic toxin?].
    Massy ZA; Drueke TB; Romet M
    Nephrol Ther; 2011 Feb; 7(1 Suppl 1):H1-4. PubMed ID: 21511201
    [No Abstract]   [Full Text] [Related]  

  • 48. Renal osteodystrophy in children with end-stage kidney failure.
    Chan JC
    Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
    Hoshino J; Ubara Y; Takaichi K
    Clin Calcium; 2004 May; 14(5):731-7. PubMed ID: 15577034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parathyroid hormone: a uremic toxin.
    Massry SG
    Adv Exp Med Biol; 1987; 223():1-17. PubMed ID: 3328951
    [No Abstract]   [Full Text] [Related]  

  • 51. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?
    Friga V; Linos A; Linos DA
    Nephron; 1997; 75(1):48-53. PubMed ID: 9031270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction by cimetidine of serum parathyroid hormone levels in uremic patients.
    Jacob AI; Lanier D; Canterbury J; Bourgoignie JJ
    N Engl J Med; 1980 Mar; 302(12):671-4. PubMed ID: 7354765
    [No Abstract]   [Full Text] [Related]  

  • 53. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

  • 54.
    Shilo V; Mor-Yosef Levi I; Abel R; Mihailović A; Wasserman G; Naveh-Many T; Ben-Dov IZ
    J Am Soc Nephrol; 2017 Aug; 28(8):2353-2363. PubMed ID: 28298326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Surgical treatment of secondary hyperparathyroidism].
    D'Alonzo U
    Minerva Med; 1985 Mar; 76(9-10):389-91. PubMed ID: 3982695
    [No Abstract]   [Full Text] [Related]  

  • 56. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
    Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
    Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcium and phosphorus in diet therapy of uremia.
    Schoolwerth AC; Engle JE
    J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium and phosphorus metabolism in uremia and renal transplantation: an experimental model.
    Mitchell TS; Lee S; Gittes RF
    Invest Urol; 1974 Nov; 12(3):186-92. PubMed ID: 4613687
    [No Abstract]   [Full Text] [Related]  

  • 59. Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications.
    Fallahzadeh MK; Roozbeh J; Geramizadeh B; Namazi MR
    Nephrol Dial Transplant; 2011 Oct; 26(10):3338-44. PubMed ID: 21372257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".
    Bricker NS
    N Engl J Med; 1972 May; 286(20):1093-9. PubMed ID: 4553202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.